2128 related articles for article (PubMed ID: 9026708)
21. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
[TBL] [Abstract][Full Text] [Related]
22. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.
Domingues CM; de Fátima Pereira S; Cunha Marreiros AC; Menezes N; Flannery B
J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
Moĭseieva HV; Zadorozhna VI
Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
[TBL] [Abstract][Full Text] [Related]
24. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
[TBL] [Abstract][Full Text] [Related]
25. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases.
Pediatrics; 1997 Feb; 99(2):300-5. PubMed ID: 9024465
[TBL] [Abstract][Full Text] [Related]
26. Polio eradication: the OPV paradox.
Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
[TBL] [Abstract][Full Text] [Related]
27. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
28. Poliovirus vaccine options.
Zimmerman RK; Spann SJ
Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
[TBL] [Abstract][Full Text] [Related]
29. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
[TBL] [Abstract][Full Text] [Related]
30. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
[TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
32. Recommended childhood immunization schedule--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
[TBL] [Abstract][Full Text] [Related]
33. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
34. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
35. [Study of immunogenicity after primary vaccination by different sequential program of inactivated poliovirus vaccine and oral poliovirus vaccine].
Lu L; Li XM; Liu DL; Zhang HR; Zhang ZJ; Wang HH; Liu F; Ning ZQ; Zhang LW; Chu P; Xie YT; Xu Y; Li J; Pang XH; Deng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jun; 46(6):510-3. PubMed ID: 22943896
[TBL] [Abstract][Full Text] [Related]
36. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
37. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
[TBL] [Abstract][Full Text] [Related]
38. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
Willis E; Sherrod JL
J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
[TBL] [Abstract][Full Text] [Related]
39. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
40. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
